Fibricor
NDC Package 13310-101-10
Package Information
Fibricor is fenofibric acid is used along with a proper diet to help lower "bad" cholesterol and fats (such as LDL, triglycerides) and raise "good" cholesterol (HDL) in the blood. Marketed by Ar Scientific, Inc., this product is identified by NDC 13310-101 and is authorized under FDA application NDA022418.
Identification & Billing
- RxCUI: 860880 - fenofibric acid 105 MG Oral Tablet
- RxCUI: 860884 - FIBRICOR 105 MG Oral Tablet
- RxCUI: 860884 - fenofibric acid 105 MG Oral Tablet [Fibricor]
- RxCUI: 860884 - Fibricor (fenofibric acid 105 MG) Oral Tablet
- RxCUI: 860884 - Fibricor 105 MG Oral Tablet
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 13310 - Ar Scientific, Inc.
- 13310-101 - Fibricor
- 13310-101-10 - 1000 TABLET in 1 BOTTLE, PLASTIC
- 13310-101 - Fibricor
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (13310-101). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 13310-101-10 identifies a specific commercial package of 1000 tablet in 1 bottle, plastic of Fibricor, labeled by Ar Scientific, Inc.. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Ar Scientific, Inc. on August 14, 2009. The current certification is valid through December 31, 2017.
What are the primary indications for this medication?
Fenofibric acid is used along with a proper diet to help lower "bad" cholesterol and fats (such as LDL, triglycerides) and raise "good" cholesterol (HDL) in the blood. It works by increasing the natural substance (enzyme) that breaks down fats in the blood. Fenofibric acid belongs to a group of drugs known as "fibrates." Lowering triglycerides in people with very high triglyceride blood levels may decrease the risk of pancreas disease (pancreatitis). However, fenofibric acid might not lower your risk of a heart attack or stroke. Talk to your doctor about the risks and benefits of fenofibric acid. In addition to eating a proper diet (such as a low-cholesterol/low-fat diet), other lifestyle changes that may help this medication work better include exercising, losing weight if overweight, and stopping smoking. Consult your doctor for more details.
How is this Ar Scientific, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 13310010110. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.
